Defective Tumour Energy Factories Boost Cancer Treatment 2 5x miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
<ul> <li><strong>Cancer Research UK-funded scientists at the Cancer Research UK Scotland Institute discover that tumours with high levels of mitochondrial DNA mutations are two and a half times more likely to respond to treatment. </strong></li> <li><strong>Link between mitochondria – which generates energy for cancer – and response to treatment shown for the first time. </strong></li> <li><strong>Discovery opens up possibility for tests to identify patients with defective mitochondria and treatments which disrupt cancer’s energy sources.</strong></li>
</ul>
Scientists discover cancer treatment two-and-a-half times more effective when tumors have defective mitochondria medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
Cancer Research UK-funded scientists have made an unusual discovery that could help to identify patients who are up to two and a half times more likely to respond to currently available cancer drugs.
<p>26 scientists have been selected to join the EMBO Young Investigator Programme, an initiative that supports excellent young group leaders in the early stages of their independent careers.</p>